🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/10/2012 | 58,12 | 58,43 | 57,17 | 57,26 | -1,28% | 2,17% | 642.400 |
| 04/10/2012 | 58,33 | 58,80 | 57,90 | 58,00 | -0,46% | 1,54% | 1.093.900 |
| 03/10/2012 | 59,00 | 59,00 | 57,89 | 58,27 | -1,09% | 1,88% | 884.700 |
| 02/10/2012 | 56,97 | 59,00 | 56,94 | 58,91 | +4,03% | 3,62% | 863.300 |
| 01/10/2012 | 56,14 | 56,95 | 55,73 | 56,63 | +1,34% | 2,17% | 1.210.600 |
| 28/09/2012 | 56,31 | 57,38 | 55,74 | 55,88 | -0,82% | 2,91% | 741.900 |
| 27/09/2012 | 56,64 | 57,16 | 56,12 | 56,34 | -0,34% | 1,84% | 479.700 |
| 26/09/2012 | 57,68 | 57,93 | 56,22 | 56,53 | -1,69% | 2,96% | 548.300 |
| 25/09/2012 | 58,37 | 58,52 | 57,45 | 57,50 | -1,37% | 1,83% | 521.300 |
| 24/09/2012 | 57,67 | 58,49 | 57,43 | 58,30 | +0,88% | 1,84% | 809.600 |
| 21/09/2012 | 58,29 | 58,93 | 57,29 | 57,79 | -0,45% | 2,81% | 1.877.900 |
| 20/09/2012 | 57,89 | 59,00 | 57,89 | 58,05 | -0,26% | 1,92% | 815.100 |
| 19/09/2012 | 58,01 | 58,42 | 57,39 | 58,20 | +0,47% | 1,78% | 882.500 |
| 18/09/2012 | 58,09 | 58,29 | 57,68 | 57,93 | -0,26% | 1,05% | 443.300 |
| 17/09/2012 | 57,25 | 58,43 | 57,12 | 58,08 | +1,63% | 2,29% | 704.400 |
| 14/09/2012 | 55,20 | 57,29 | 55,03 | 57,15 | +4,10% | 4,09% | 759.100 |
| 13/09/2012 | 54,68 | 55,15 | 53,81 | 54,90 | +0,29% | 2,45% | 488.100 |
| 12/09/2012 | 55,18 | 55,38 | 54,61 | 54,74 | -0,47% | 1,40% | 382.900 |
| 11/09/2012 | 54,80 | 55,57 | 54,76 | 55,00 | +0,26% | 1,48% | 608.000 |
| 10/09/2012 | 55,02 | 55,20 | 53,95 | 54,86 | -0,60% | 2,27% | 1.272.700 |
| 07/09/2012 | 55,82 | 55,90 | 55,03 | 55,19 | -0,90% | 1,56% | 291.500 |
| 06/09/2012 | 55,94 | 56,25 | 55,64 | 55,69 | -0,07% | 1,09% | 441.400 |
| 05/09/2012 | 55,83 | 55,96 | 55,35 | 55,73 | +0,13% | 1,09% | 580.300 |
| 04/09/2012 | 54,20 | 55,71 | 54,00 | 55,66 | +2,85% | 3,15% | 779.600 |
| 31/08/2012 | 54,32 | 54,40 | 53,55 | 54,12 | +0,28% | 1,56% | 393.300 |
| 30/08/2012 | 55,03 | 55,07 | 53,72 | 53,97 | -2,44% | 2,45% | 616.100 |
| 29/08/2012 | 55,83 | 55,98 | 55,14 | 55,32 | -0,68% | 1,50% | 253.000 |
| 28/08/2012 | 55,35 | 55,94 | 55,06 | 55,70 | +0,81% | 1,59% | 785.500 |
| 27/08/2012 | 55,64 | 55,91 | 55,12 | 55,25 | -0,14% | 1,42% | 288.700 |
| 24/08/2012 | 55,28 | 55,68 | 55,04 | 55,33 | +0,20% | 1,16% | 226.000 |